Page 93 - Mutation News Today

SARS-CoV-2 spike E484K mutation reduces antibody neutralization Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, the coronavirus disease 2019 (COVID-19) pandemic continues to wreak havoc globally. Meanwhile, scientists race to develop therapeutics and vaccines to mitigate its severity and control its spread. However, faster spreading and potentially more fatal SARS-CoV-2 variants have undermined efforts to turn the tide of the pandemic. Researchers at the Dep...

More than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the global mechanism for equitable access to COVID-19 vaccines. The milestone comes 42 days after the first COVAX doses were shipped and delivered internationally, to Ghana on 24 February 2021.

We ask our science correspondent Derrick Williams if there is a link between mass vaccination and mutation of the coronavirus.

Conjunctivitis, headache, diarrhea, and discolored fingers and toes are new symptoms of COVID-19 Fever, dry cough, breathlessness and loss of smell were the original symptoms of the COVID-19 virus New Delhi: Its been more than a year since the deadly coronavirus wreaked havoc in our country, and even after several efforts to contain the spread of it, the second wave of the virus is currently spreading like wildfire in the nation. While we all know the most common symptoms for COVID are dry coug...

As members of the Lancet Covid-19 Commission Taskforce on Public Health, we call for urgent action in response to the new variants. These new variants mean we cannot rely on the vaccines alone to provide protection but must maintain strong public health measures to reduce the risk from these variants. At the same time, we need to accelerate the vaccine programme in all countries in an equitable way. Together, these strategies will deliver “maximum suppression” of the virus. What are ‘v...

South Africa SARS-CoV-2 variant B.1.351 easily escapes Sputnik vaccine The current pandemic of novel coronavirus disease 2019 (COVID-19) was caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has undergone numerous mutations in its genome to emerge as different variants. As of now, a dozen vaccines have received emergency use authorization, and many countries around the world have initiated mass vaccination campaigns. A new preprint research paper posted to the m...

CAL20.C SARS-CoV-2 variant skyrocketing in California evades host immune response The effect of different neutralizing antibodies, both vaccine-elicited and from convalescent sera, suggests new variants are emerging that can evade the human immune response. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to host cells via its spike protein, which has two parts, the S1 and S2 subunits. The S1 subunit has the receptor-binding domain (RBD) and the N-terminal domain (NTD). Th...

By Reuters Staff 2 Min Read JAKARTA (Reuters) - Indonesia has reported its first case of a more transmissible new variant of the coronavirus known for reducing vaccine protection, but the government on Tuesday said vaccines being used in the country could withstand the mutation. The new variant contains the E484K mutation found in variants first identified in South Africa and Brazil. It is nicknamed “Eek” by some scientists for its apparent ability to evade natural immunity from previous CO...

Known for reducing vaccine protection, it was seen in nearly 70% of patients at Tokyo Hospital

The E484K mutation, nicknamed "Eek" by some scientists, was found in 10 of 14 people who tested positive for the virus at Tokyo Medical and Dental University Medical Hospital in March, the report said.